Investigation for the possibility of CaMKII activity modulation for the therapeutic optical in rheumatoid arthritis
Investigation for the possibility of CaMKII activity modulation for the therapeutic optical in rheumatoid arthritis
批准号:
18591116
负责人:
KAWAKAMI Atsushi
金额:
$2.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The remarkable proliferation as well as apoptosis resistance are crucial for rheumatoid arthritis (RA). Among them, we have focused on the importance of PI3K/Akt pathway, and in the current 2 years, we have tried to investigate the role of CaMKII pathway. FLS in culture expressed CaMKII γ and δ, especially δ isoform. The addition of CaMKII chemical inhibitor, KN93, significantly augmented apoptosis sensitivity of FLS in response to TRAIL and anti-Fas antibody. The additional experiment showed that CaMKII-induced phenomena of apoptosis sensitivity are mediated through Akt. CaMKII is an enzyme that is activated by Ca ion influx. Ca ion influx also activates PADI, which is an essential enzyme for post-transcriptional mechanism of peptide citrullination. Post-transcriptional mechanism of peptide citrullination is thought to be crucial for anti-CCP antibodies production in patients with RA, a RA-specific autoantibodies. However, we could not detect the citrullinated peptides in cultured FLS in response to Ca ion influx, pro-inflammatory cytoltines or pro-apoptotic stimuli. Thus, we conducted the experiment by the use of human cell line, HL-60. HL-60 expressed CaMKII γ isoform. A significant expression of PADI4, citrullinated peptides and Akt phosphorylation was found during the course of granulocyte-lineage differentiation of HL-60 by ATRA According to the results obtained in the current 2 years, an association between CaMKII and FLS apoptosis is demonstrated. Considering a possible cross-talk between CaMKII and Akt, another cross-talk among CaMKII, Akt and the peptide citrullination process appears to be present. These mechanisms are thought to be important research issue of RA that strengthens a role of CaMKII for a target molecule in RA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
EGF activates PI3K-Akt and NF-kappaB via distinct pathways in salivary epithelial cells in Sjogren's syndrome
EGF 通过干燥综合征唾液上皮细胞中的不同途径激活 PI3K-Akt 和 NF-kappaB
DOI:
--
发表时间:
2007
期刊:
Rheumatology international 28(2)
影响因子:
--
作者:
[Nakamura H, Kawakami A, Eguchi K(2番目, 他2名)]
通讯作者:
他2名)
Mechanisms of autoantibody production and the relationship between antuantibodies and the clinical manifestations in Sjogren's syndrome
干燥综合征自身抗体产生机制及抗体与临床表现的关系
DOI:
--
发表时间:
2006
期刊:
Translafional Res 148(6)
影响因子:
--
作者:
[Nakamura H, Kawakami A, Eguchi K]
通讯作者:
Eguchi K
関節リウマチの早期診断と早期からの骨病変進展予測の試み
类风湿关节炎早期诊断和骨病变进展早期预测的尝试
DOI:
--
发表时间:
2006
期刊:
臨床リウマチ 18(4)
影响因子:
--
作者:
[川上 純, 江口 勝美(1番目, 他7名)]
通讯作者:
他7名)
関節リウマチに対するinfliximabの長期治療効果と安全性:102週での検討
英夫利昔单抗治疗类风湿关节炎的长期疗效和安全性:102 周研究
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Kawakami A(筆頭著者, 他13名), Tamai M, Tamai M, 玉井 慎美, 岩本 直樹, 玉井 慎美, 岩本 直樹, 中村 英樹, 有馬 和彦, 玉井 慎美, 藤川 敬太, 荒牧 俊幸, 右田 清志, 荒牧 俊幸, 藤川 敬太, 玉井 慎美, 岩永 希, 折口 智樹, 岩永 希]
通讯作者:
岩永 希
Prognostic Evaluation of Undifferentiated Arthritis (UA) at Baseline Through Magnetic Resonance Imaging (MRI)-Detection of Early Join Damages and Serologic Variables:Results from the Prospective Clinical Study
通过磁共振成像 (MRI) 检测早期关节损伤和血清学变量对基线未分化关节炎 (UA) 进行预后评估:前瞻性临床研究的结果
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Tamai M, Kawakami A, et. al.]
通讯作者:
et. al.
共 70 条
Basic research for searching of new therapeutic targets of rheumatoid arthritis through investigation of novel action of CTLA-4-Ig
-
批准号:15K09531
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:KAWAKAMI Atsushi
-
依托单位:
Investigation of autoantigens in patients with rheumatoid arthritis through protemic analysis: exploration from diagnosis, pathogenesis to therapy
-
批准号:23591439
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2011
-
负责人:KAWAKAMI Atsushi
-
依托单位:
Cell and signal mechanisms that support tissue regeneration in fish
-
批准号:21570004
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:KAWAKAMI Atsushi
-
依托单位:
Can we explain the varying pathologic processes of rheumatoid arthritis by CaMKII delta abnormality?
-
批准号:20591173
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:KAWAKAMI Atsushi
-
依托单位:
Basic research for the molecular mechanism of regeneration in bone and cartilage by the fibroblast-like synovial cells
-
批准号:14570420
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2002
-
负责人:KAWAKAMI Atsushi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
土家药血筒三萜调控Sema4D/PlexinB1信号轴抑制功能细胞串扰抗RA的机制研究
-
批准号:2026JJ80908
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:余黄合
-
依托单位:
基于“大气下陷”理论探讨升陷汤调控IL-17A/IL-17RA信号轴抑制MMP-2/MMP-9表达抗心衰大鼠心肌纤维化的作用机制
-
批准号:2026JJ80502
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王雪
-
依托单位:
通痹颗粒抑制糖代谢重编程调控巨噬细胞极化治疗RA的机制研究
-
批准号:2026JJ82264
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺选玲
-
依托单位:
基于质谱成像及巨噬细胞糖代谢重编程研究土家药血筒总三萜抗RA作用机制
-
批准号:2026JJ50633
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:袁汉文
-
依托单位:
感觉神经元上 IL17ra 调控银屑病慢性瘙痒机制研究
-
批准号:JCZRQNB202600192
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
ITP患者细胞亚群及免疫因子表达谱对TPO-RA干预后巨核细胞分化和网织血小板增生影响机制研究
-
批准号:JCZRLH202601080
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IL-36α/IL-36RA 调控杯状细胞在接触镜干眼小鼠模型中的作用
-
批准号:ZCLQN26H1201
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:林娜
-
依托单位:
面向复杂系统机制解析的因果发现与可解释AI基础模型研究—以西藏凹乳芹抗RA为例
-
批准号:JCZRMS202602232
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
中医证型与RA-SS风险的关联机制:一项人群队列与代谢组学研究
-
批准号:JCZRLH202601121
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
霍尔德曼氏菌抑制色氨酸-吲哚-AhR通路介导TNF-α拮抗剂治疗RA耐药的机制研究
-
批准号:2026JJ60257
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵青
-
依托单位: